Literature DB >> 22242702

The new ILAE report on terminology and concepts for the organization of epilepsies: critical review and contribution.

Chrysostomos P Panayiotopoulos1.   

Abstract

This critical review refers to the new report on terminology and concepts for the organization of epilepsies by the Commission of the International League Against Epilepsy (ILAE). It is unfortunate that most of the proposals in the Commission's report are modified interpretations and nomenclature of previous ILAE classifications; new terms are not better than the old ones, and recent advances have not been incorporated. Hence, the new ILAE report met with considerable dissatisfaction from several expert epileptologists. The Commission abandoned (1) the disease-syndrome distinction, although "disease" is generally differentiated from "syndrome" in most medical texts as well as in the ILAE classification itself; (2) the distinction of "generalized" and "focal" for epileptic syndromes, despite maintaining this distinction for epileptic seizures and despite the fact that most epileptic syndromes manifest exclusively either with generalized or focal epileptic seizures; (4) the terms "idiopathic,""symptomatic," and "cryptogenic," although these terms have been well defined in the previous ILAE classifications; reiterating their true meaning would be sufficient. Genetic epilepsy could be a new category and (5) the designation of "benign" epilepsies, despite the recommendations of experts at the Monreale workshop. In addition, the Commission proposed that "age at onset" be used as a primary dimension for organizing the epilepsies. However, (a) this runs counter to classification efforts of other diseases in medicine and neurology; (b) syndromes that are likely to be linked together on the basis of electroclinical (and often genetic) evidence are now separated and intermixed with a number of heterogeneous epilepsies; and (c) a considerable number of epileptic syndromes have a wide range of age at onset from childhood to adulthood. Furthermore, epilepsy syndromes were given by name only, without definition; thus we remain dependent on previous ILAE definitions, which are often broad and imprecise. The ILAE should commission consensus of opinion from experts in specific fields in order to define each syndrome. Areas of certainties and uncertainties and of agreements and disagreements should be identified and explained. This approach may be the only way toward achieving a scientifically sound and clinically meaningful organizational system for the epileptic seizures and the epilepsies-a process that would incorporate the tremendous advances in our field and would be accepted by the wider community of clinicians and scientists. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2012        PMID: 22242702     DOI: 10.1111/j.1528-1167.2011.03381.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  13 in total

1.  Consensus Over Individualism: Validation of the ILAE Definition for Drug Resistant Epilepsy.

Authors:  Barbara C Jobst
Journal:  Epilepsy Curr       Date:  2015 Jul-Aug       Impact factor: 7.500

Review 2.  Inflammatory pathways of seizure disorders.

Authors:  Nicola Marchi; Tiziana Granata; Damir Janigro
Journal:  Trends Neurosci       Date:  2013-12-16       Impact factor: 13.837

3.  ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.

Authors:  Ingrid E Scheffer; Samuel Berkovic; Giuseppe Capovilla; Mary B Connolly; Jacqueline French; Laura Guilhoto; Edouard Hirsch; Satish Jain; Gary W Mathern; Solomon L Moshé; Douglas R Nordli; Emilio Perucca; Torbjörn Tomson; Samuel Wiebe; Yue-Hua Zhang; Sameer M Zuberi
Journal:  Epilepsia       Date:  2017-03-08       Impact factor: 5.864

Review 4.  State of the Art Approach to the Classification of Epileptic Seizures and Epilepsies.

Authors:  Ebru Barçin; Berrin Aktekin
Journal:  Noro Psikiyatr Ars       Date:  2014-09-01       Impact factor: 1.339

5.  Predictive value of S100-B and copeptin for outcomes following seizure: the BISTRO International Cohort Study.

Authors:  Yonathan Freund; Benjamin Bloom; Jerome Bokobza; Nacera Baarir; Said Laribi; Tim Harris; Vincent Navarro; Maguy Bernard; Rupert Pearse; Bruno Riou; Pierre Hausfater
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

6.  Contribution of GABRG2 Polymorphisms to Risk of Epilepsy and Febrile Seizure: a Multicenter Cohort Study and Meta-analysis.

Authors:  Batoul Sadat Haerian; Larry Baum; Patrick Kwan; Stacey S Cherny; Jae-Gook Shin; Sung Eun Kim; Bok-Ghee Han; Hui Jan Tan; Azman Ali Raymond; Chong Tin Tan; Zahurin Mohamed
Journal:  Mol Neurobiol       Date:  2015-10-09       Impact factor: 5.590

7.  Epilepsy in the end-of-life phase in patients with high-grade gliomas.

Authors:  Andrea Pace; Veronica Villani; Cherubino Di Lorenzo; Lara Guariglia; Marta Maschio; Alfredo Pompili; Carmine Maria Carapella
Journal:  J Neurooncol       Date:  2012-10-20       Impact factor: 4.130

8.  Seizures as an early symptom of autosomal dominant Alzheimer's disease.

Authors:  Jonathan Vöglein; Soheyl Noachtar; Eric McDade; Kimberly A Quaid; Stephen Salloway; Bernardino Ghetti; James Noble; Sarah Berman; Jasmeer Chhatwal; Hiroshi Mori; Nick Fox; Ricardo Allegri; Colin L Masters; Virginia Buckles; John M Ringman; Martin Rossor; Peter R Schofield; Reisa Sperling; Mathias Jucker; Christoph Laske; Katrina Paumier; John C Morris; Randall J Bateman; Johannes Levin; Adrian Danek
Journal:  Neurobiol Aging       Date:  2018-12-05       Impact factor: 5.133

9.  The Peptide Network between Tetanus Toxin and Human Proteins Associated with Epilepsy.

Authors:  Guglielmo Lucchese; Jean Pierre Spinosa; Darja Kanduc
Journal:  Epilepsy Res Treat       Date:  2014-06-01

Review 10.  Epilepsy in cats: theory and practice.

Authors:  A Pakozdy; P Halasz; A Klang
Journal:  J Vet Intern Med       Date:  2014-01-17       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.